OVOL2 induces autophagy-mediated epithelial-mesenchymal transition by the ERK1/2 MAPK signaling in lung adenocarcinoma DOI Creative Commons
Yali Wang,

Lin Shi,

Yuchao He

et al.

iScience, Journal Year: 2024, Volume and Issue: 27(2), P. 108873 - 108873

Published: Jan. 11, 2024

Lung adenocarcinoma (LUAD) is one of the leading causes cancer-related death worldwide. Epithelial-mesenchymal transition (EMT) plays an important role in malignant tumor progression. Recently, accumulating evidence has shown that autophagy involved regulation EMT-induced migration. Therefore, exploration targets to inhibit EMT by targeting important. In this study, we found OVO-like zinc finger 2 (OVOL2) may be a key target for regulating autophagy-induced EMT. Firstly, OVOL2 expression was dramatically downregulated LUAD. Low indicator poor prognosis

Language: Английский

Targeting the RAS/RAF/MAPK pathway for cancer therapy: from mechanism to clinical studies DOI Creative Commons
Md Entaz Bahar, Hyun Joon Kim, Deok Ryong Kim

et al.

Signal Transduction and Targeted Therapy, Journal Year: 2023, Volume and Issue: 8(1)

Published: Dec. 18, 2023

Metastatic dissemination of solid tumors, a leading cause cancer-related mortality, underscores the urgent need for enhanced insights into molecular and cellular mechanisms underlying metastasis, chemoresistance, mechanistic backgrounds individuals whose cancers are prone to migration. The most prevalent signaling cascade governed by multi-kinase inhibitors is mitogen-activated protein kinase (MAPK) pathway, encompassing RAS-RAF-MAPK (MEK)-extracellular signal-related (ERK) pathway. RAF primary mediator MAPK responsible sequential activation downstream targets, such as MEK transcription factor ERK, which control numerous physiological processes, including organism development, cell cycle control, proliferation differentiation, survival, death. Defects in this associated with diseases cancer. (RAFi) combined blockers represent an FDA-approved therapeutic strategy RAF-mutant cancers, melanoma, non-small lung carcinoma, thyroid However, development therapy resistance cancer cells remains important barrier. Autophagy, intracellular lysosome-dependent catabolic recycling process, plays critical role RAFi Thus, targeting autophagy could be novel treatment strategies cancers. In review, we delve deeper surrounding tumorigenesis RAFi-resistance. Furthermore, explore discuss ongoing next-generation profiles. Additionally, review sheds light on functional interplay between RAF-targeted therapies

Language: Английский

Citations

244

Advanced drug delivery platforms target cancer stem cells DOI Creative Commons

MirAhmad Mazloomi,

Abolfazl Doustmihan, Sajjad Alimohammadvand

et al.

Asian Journal of Pharmaceutical Sciences, Journal Year: 2025, Volume and Issue: unknown, P. 101036 - 101036

Published: Feb. 1, 2025

Citations

3

Medicinal and mechanistic overview of artemisinin in the treatment of human diseases DOI Creative Commons
Anna Maria Posadino, Roberta Giordo, Gianfranco Pintus

et al.

Biomedicine & Pharmacotherapy, Journal Year: 2023, Volume and Issue: 163, P. 114866 - 114866

Published: May 12, 2023

Artemisinin (ART) is a bioactive compound isolated from the plant Artemisia annua and has been traditionally used to treat conditions such as malaria, cancer, viral infections, bacterial some cardiovascular diseases, especially in Asia, North America, Europe other parts of world. This comprehensive review aims update biomedical potential ART its derivatives for treating human diseases highlighting pharmacokinetic pharmacological properties based on results experimental studies vitro vivo. Cellular molecular mechanisms action, tested doses toxic effects artemisinin were also described. The analysis data an up-to-date literature search showed that display anticancer along with wide range activities antibacterial, antiviral, antimalarial, antioxidant cardioprotective effects. These compounds have great discovering new drugs adjunctive therapies cancer various diseases. Detailed translational are however needed fully understand these compounds.

Language: Английский

Citations

38

Cell death pathways: molecular mechanisms and therapeutic targets for cancer DOI Creative Commons
Shaohui Wang, Sa Guo, Jing Guo

et al.

MedComm, Journal Year: 2024, Volume and Issue: 5(9)

Published: Sept. 1, 2024

Abstract Cell death regulation is essential for tissue homeostasis and its dysregulation often underlies cancer development. Understanding the different pathways of cell can provide novel therapeutic strategies battling cancer. This review explores several key mechanisms apoptosis, necroptosis, autophagic death, ferroptosis, pyroptosis. The research gap addressed involves a thorough analysis how these be precisely targeted therapy, considering tumor heterogeneity adaptation. It delves into genetic epigenetic factors signaling cascades like phosphatidylinositol 3‐kinase/protein kinase B/mammalian target rapamycin (PI3K/AKT/mTOR) mitogen‐activated protein kinase/extracellular signal‐regulated (MAPK/ERK) pathways, which are critical death. Additionally, interaction microenvironment with cells, particularly influence hypoxia, nutrient deprivation, immune cellular interactions, explored. Emphasizing strategies, this highlights emerging modulators inducers such as B lymphoma 2 (BCL2) homology domain 3 (BH3) mimetics, tumour necrosis factor‐related apoptosis‐inducing ligand (TRAIL), chloroquine, innovative approaches to induce ferroptosis provides insights therapy's future direction, focusing on multifaceted circumvent drug resistance. examination evolving underlines considerable clinical potential continuous necessity in‐depth exploration within scientific domain.

Language: Английский

Citations

14

Establishment of a novel lysosomal signature for the diagnosis of gastric cancer with in-vitro and in-situ validation DOI Creative Commons
Qi Wang, Ying Liu,

Zhangzuo Li

et al.

Frontiers in Immunology, Journal Year: 2023, Volume and Issue: 14

Published: May 5, 2023

Background Gastric cancer (GC) represents a malignancy with multi-factorial combination of genetic, environmental, and microbial factors. Targeting lysosomes presents significant potential in the treatment numerous diseases, while lysosome-related genetic markers for early GC detection have not yet been established, despite implementing this process by assembling artificial intelligence algorithms would greatly break through its value translational medicine, particularly immunotherapy. Methods To end, study, utilizing transcriptomic as well single cell data integrating 20 mainstream machine-learning (ML) algorithms. We optimized an AI-based predictor diagnosis. Then, reliability model was initially confirmed results enrichment analyses currently use. And immunological implications genes comprising explored response patients were evaluated to immunotherapy chemotherapy. Further, we performed systematic laboratory work evaluate build-up central genes, both at expression stage functional aspect, which could also demonstrate guide Results Eight lysosomal-related selected predictive construction based on inclusion RMSE reference standard RF algorithm ranking, namely ADRB2, KCNE2, MYO7A, IFI30, LAMP3, TPP1, HPS4, NEU4. Taking into account accuracy, precision, recall, F1 measurements, preliminary determination our study carried out means applying extra tree random forest algorithms, incorporating ROC-AUC consideration, Extra Tree seems be optimal option AUC 0.92. The superiority diagnostic signature is reflected analysis immune features. Conclusion In summary, first integrate around ML construct gastric genes. This will facilitate accurate prediction incidence subsequent risk assessment or precise individualized immunotherapy, thus improving survival prognosis patients.

Language: Английский

Citations

18

Nutrition and dietary restrictions in cancer prevention DOI
Amrendra Mishra,

Giacomo Giuliani,

Valter D. Longo

et al.

Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, Journal Year: 2023, Volume and Issue: 1879(1), P. 189063 - 189063

Published: Dec. 24, 2023

Language: Английский

Citations

14

Cancer Pathways Targeted by Berberine: Role of microRNAs DOI
Mansoor Ali, Deepali Mishra, Rana P. Singh

et al.

Current Medicinal Chemistry, Journal Year: 2024, Volume and Issue: 31(32), P. 5178 - 5198

Published: Feb. 2, 2024

Cancer is a complex and heterogeneous malignant disease. Due to its multifactorial nature, including progressive changes in genetic, epigenetic, transcript, protein levels, conventional therapeutics fail save cancer patients. Evidence indicates that dysregulation of microRNA (miRNA) expression plays crucial role tumorigenesis, metastasis, cell proliferation, differentiation, metabolism, signaling pathways. Moreover, miRNAs can be used as diagnostic prognostic markers therapeutic targets cancer. Berberine, naturally occurring plant alkaloid, has wide spectrum biological activities different types cancers. Inhibition migration, invasion, angiogenesis, well induction cycle arrest apoptosis cells, reported by berberine. Recent studies suggested berberine regulates many oncogenic tumor suppressor implicated phases This review discussed how inhibits growth propagation cells. And berberine-mediated miRNA regulation the landscape transcripts proteins promote or suppress progression. Overall, underlying molecular pathways altered influencing pathophysiology will enhance our understanding combat malignancy.

Language: Английский

Citations

5

Autophagy modulation in cancer therapy: Challenges coexist with opportunities DOI
Yongya Wu,

Aoxue Wang,

Guotai Feng

et al.

European Journal of Medicinal Chemistry, Journal Year: 2024, Volume and Issue: 276, P. 116688 - 116688

Published: July 17, 2024

Language: Английский

Citations

5

Targeting autophagy can synergize the efficacy of immune checkpoint inhibitors against therapeutic resistance: New promising strategy to reinvigorate cancer therapy DOI Creative Commons

Mehrdad Hashemi,

Elaheh Mohandesi Khosroshahi,

Mahsa Tanha

et al.

Heliyon, Journal Year: 2024, Volume and Issue: 10(18), P. e37376 - e37376

Published: Sept. 1, 2024

Language: Английский

Citations

4

Advancements in a novel model of autophagy and immune network regulation in radioresistance of cancer stem cells DOI Open Access

Leyao Li,

Xin Wang,

Mei Jiang

et al.

Biomedicine & Pharmacotherapy, Journal Year: 2024, Volume and Issue: 179, P. 117420 - 117420

Published: Sept. 9, 2024

Language: Английский

Citations

4